The DSB annual industry consultation plays a vital role in shaping the DSB’s services. Stakeholders are encouraged to participate to ensure a broad range of views are considered, so the DSB can continue to meet the needs of its user community.

Consistent with previous years, timings are being communicated in advance to give market participants sufficient notice to respond. The consultation paper will be published on 30 April 2024, and the industry will have until 31 May 2024 to submit responses. The Final Report will be published on 16 July 2024. The full timeline can be found on the DSB website. The consultation supports the development of DSB services by focussing on aspects of its services that users have highlighted for development consideration and optimisation, or to address evolving market practices and technological advances. For the first time, this year’s consultation will include the new UPI services, which is particularly relevant as G20 regulatory reporting mandates go live throughout 2024 and 2025. Key topics that will be covered include: • User type functionality, including intermediaries • The Traded on a Trading Venue (ToTV) Service • Fair cost apportionment across service provisions

The DSB continues to uphold the development and adoption of OTC derivative identifier standards that promote market interoperability through the work of the DSB Product Committee, the Technology Advisory Committee and the recently launched Governance Advisory Committee.

The consultation, in conjunction with the ongoing complementary work of the DSB industry representation groups, is designed to provide an opportunity for the DSB’s broad and varied user community to contribute, ensuring that services remain fit for purpose and evolve in line with the needs of the industry.

Emma Kalliomaki, Managing Director of ANNA and the DSB, said: “We appreciate the ongoing engagement and collaboration of all stakeholders in shaping DSB Services.

We recognize that evolving regulations and market developments place diverse demands on firms’ resources which is why we offer advance notice to the consultation milestones to facilitate valuable input from our stakeholders. Our commitment to providing global OTC derivative identifier standards and services that meet industry requirements remains a key focus for the DSB.”

For more information about how to get involved with the consultation process, please contact us via This email address is being protected from spambots. You need JavaScript enabled to view it.. All other questions can be directed to This email address is being protected from spambots. You need JavaScript enabled to view it..